0 items USD 0.00Search
- Did you mean
- leukodystrophy (ald)
Your search for "Adrenoleukodystrophy (ALD)" gave back 2692 results.
Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...
颁补迟补濒辞驳:听
Global Markets Direct
September 2022
Price: USD 2,000.00
Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) - Drugs in Development, 2021 Summary Global Markets Direct's latest...
颁补迟补濒辞驳:听
Global Markets Direct
September 2021
Price: USD 2,000.00
The global Adrenoleukodystrophy Drugs market size is predicted to grow from US$ 443 million in 2025 to US$ 1107 million in 2031; it is expected to...
颁补迟补濒辞驳:听
LPI
January 2025
Price: USD 3,660.00
The global market for Adrenoleukodystrophy Drugs was valued at US$ 453 million in the year 2024 and is projected to reach a revised size of US$ 1254...
颁补迟补濒辞驳:听
MRRPB5
April 2025
Price: USD 2,900.00
Adrenoleukodystrophy (ALD) is a rare, genetic, X-linked metabolic disorder caused by mutations in the ABCD1 gene that result in a deficiency in a...
颁补迟补濒辞驳:听
MRRPB5
February 2024
Price: USD 2,900.00
The global Adrenoleukodystrophy Drugs market size was valued at US$ 330.5 million in 2023. With growing demand in downstream market, the...
颁补迟补濒辞驳:听
LPI
January 2024
Price: USD 3,660.00
Adrenoleukodystrophy (ALD) is a rare, genetic, X-linked metabolic disorder caused by mutations in the ABCD1 gene that result in a deficiency in a...
颁补迟补濒辞驳:听
MRRPB5
January 2023
Price: USD 2,900.00
Adrenoleukodystrophy (ALD) is a rare, genetic, X-linked metabolic disorder caused by mutations in the ABCD1 gene that result in a deficiency in a...
颁补迟补濒辞驳:听
MRRPB5
April 2024
Price: USD 3,950.00
The global Adrenoleukodystrophy Drugs market size was valued at US$ 466 million in 2024 and is forecast to a readjusted size of USD 1266 million by...
颁补迟补濒辞驳:听
GIR
July 2025
Price: USD 3,480.00
Adrenoleukodystrophy (ALD) is a rare, genetic, X-linked metabolic disorder caused by mutations in the ABCD1 gene that result in a deficiency in a...
颁补迟补濒辞驳:听
GIR
September 2024
Price: USD 3,480.00
Our latest Pharmaceutical and Healthcare disease pipeline guide Adrenoleukodystrophy - Pipeline Review, H1 2018, provides an overview of the...
颁补迟补濒辞驳:听
Global Markets Direct
May 2018
Price: USD 2,000.00
Adrenoleukodystrophy refers to a rare genetic condition that causes the buildup of long chain fatty acids (VLCFAs) in the brain. ALD is led by a...
颁补迟补濒辞驳:听
MRRPB5
March 2023
Price: USD 2,900.00
Adrenoleukodystrophy refers to a rare genetic condition that causes the buildup of long chain fatty acids (VLCFAs) in the brain. ALD is led by a...
颁补迟补濒辞驳:听
MRRPB5
December 2024
Price: USD 3,950.00
Adrenoleukodystrophy refers to a rare genetic condition that causes the buildup of long chain fatty acids (VLCFAs) in the brain. ALD is led by a...
颁补迟补濒辞驳:听
MRRPB5
August 2024
Price: USD 2,900.00
Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) - Pipeline Review, H2 2018 Summary Global Markets Direct's latest...
颁补迟补濒辞驳:听
Global Markets Direct
November 2018
Price: USD 2,000.00
听
